Moderna’s stock hit as flu-vaccine trial fails on one target. Meanwhile, China declares victory over COVID.
February 17, 2023 at 10:51 AM EST
Moderna Inc.'s stock slid 5% Friday, after the COVID vaccine maker said a trial of a flu-vaccine candidate failed to meet one of its goals.
